Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-10-002212
Filing Date
2010-04-27
Accepted
2010-04-27 20:36:11
Documents
1
Period of Report
2010-04-19

Document Format Files

Seq Description Document Type Size
1 c61277_ex.html 4  
1 c61277_ex.xml 4 5972
  Complete submission text file 0000930413-10-002212.txt   8055
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Business Address
Deuel Thomas (Reporting) CIK: 0001405880 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 10774905